Kyrgyzstan is due to receive 4,500 antibody tests from WHO

AKIPRESS.COM - Kyrgyzstan is expecting to receive 4,500 enzyme-linked immunosorbent assay (‎ELISA) from World Health Organization, said Nurbolot Usenbayev on May 28.
"Today, our efforts are aimed at launching research on antibodies in the country, to determine the number of immune persons, to identify persons who were already in contact and how many people can confront coronavirus. Our specialists prepared screening research program among the population," he said.
We consider two proposals on enzyme immunoassay supply. We will start screening studies among population immediately upon receipt of ELISA tests, he added.
Enzyme-Linked Immunosorbent Assays (ELISAs) are the most widely used type of assay. They have evolved from viral lysate tests to tests containing recombinant protein and synthetic peptide antigens:
- They have high sensitivity and specificity.
- ELISAs are designed specifically for screening large numbers of specimens at a time, making them suitable for use in surveillance and centralized blood transfusion services.
- As ELISAs require sophisticated equipment and skilled technicians to perform the tests, their use is limited to certain circumstances.